HEALTHCARE

24 Mar 2015

Dr. Michael’s Dental Clinic Highlights Saving Your Natural Teeth on Root Canal Awareness Week

If you need a root canal, see an endodontist

Root canals don’t cause pain – they relieve it


In support of the Root Canal Awareness Week which runs from March 22-28, 2015, Dr. Yasmin Al-Zoubaidy, Root Canal Specialist at Dr. Michael’s Dental Clinic aims to dispel myths about root canal treatment (RCT) and advocates the special"......

Continue Reading

24 Mar 2015

Cricketing legend Sachin Tendulkar to be the face of Aster Pharmacy; launches 150th outlet

Aster DM Healthcare, a healthcare provider with presence in the Middle East and India, announced legendary cricketer and recipient of the Bharat Ratna Mr. Sachin Tendulkar, as the global face and brand ambassador of the Aster Pharmacy vertical.

Mr."...

Continue Reading

23 Mar 2015

New Study Comparing ABThera™ to BVPT, Published in the Annals of Surgery, Demonstrated Reduced 90-Day Mortality

Acelity L.P., Inc. announced today the publication of the results from a single center, prospective, randomized controlled trial comparing the ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT) to the Barker’s vacuum packing technique (BVPT).1 The investigator-initiated"...

Continue Reading

21 Mar 2015

Oral OTEZLA® (apremilast) Long-Term Safety and Efficacy Data in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD

OTEZLA improved the severity of palmoplantar psoriasis at week 16 in a subset of patients across three trials


Long-term safety profile for up to 104 weeks in ESTEEM 1 was consistent with previously reported data from OTEZLA clinical trial programs, with no new safety signals and no clinically meaningful changes"......

Continue Reading

21 Mar 2015

Boehringer Ingelheim’s investigational biologic cleared skin better than ustekinumab in head-to-head Phase II psoriasis study

  • Nearly double the percentage of patients on BI 655066 with clear or almost clear skin (PASI 90) after 12 weeks vs. ustekinumab1
  • BI 655066 selectively blocks IL-23, a key protein involved in psoriatic skin inflammation1

For non-UK/non-Canadian media only


...

Continue Reading

21 Mar 2015

Positive Results from Phase III Study Evaluating Oral OTEZLA® (Apremilast) or Injectable Etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD

More patients achieved a PASI-75 response at week 32 than at week 16 for those randomized to OTEZLA at baseline and those switched from etanercept to OTEZLA at week 16


In a post-hoc analysis of PASI-75 at week 16, there was no statistically significant difference between OTEZLA and etanercept


......

Continue Reading

19 Mar 2015

Phase II Data for Celgene’s Investigational Oral GED-0301 for Patients with Active Crohn’s Disease Published in New England Journal of Medicine

65 percent of patients treated with GED-0301 160 mg once daily for two weeks achieved clinical remission at both day 15 and day 28, versus 10 percent of patients on placebo


72 and 67 percent of patients treated with 160 mg once daily were in clinical remission at day 28 and at day 84, respectively


......

Continue Reading

18 Mar 2015

Queen Mary University of London Wins 2014 Terumo BCT Plasma Exchange Innovation Award

Terumo BCT is pleased to announce that Queen Mary University of London (QMUL) has been named the recipient of the 2014 Plasma Exchange Innovation Award. The award is part of a program that"......

Continue Reading

16 Mar 2015

Many Atrial Fibrillation patients at high risk of stroke fail to receive guideline-recommended oral anticoagulant treatment

  • New analyses highlight undertreatment of high-risk AF patients1,2
  • First Phase II data demonstrating anticoagulant prescribing patterns in North America now available from GLORIA™-AF Registry Program
  • Results presented at American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15)


...

Continue Reading
Found articles: 29 - Pages  « 3 
Contact US | Powered by CNPHUB.com - All Rights Reserved